Short Interest in Ainos, Inc. (NASDAQ:AIMD) Expands By 43.2%

Ainos, Inc. (NASDAQ:AIMD) was the target of a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 161,800 shares, an increase of 43.2% from the November 15th total of 113,000 shares. Approximately 3.9% of the company’s shares are sold short. Based on an average trading volume of 364,100 shares, the days-to-cover ratio is presently 0.4 days.

Ainos Trading Down 7.3 %

Shares of NASDAQ AIMD opened at $0.44 on Friday. Ainos has a 52-week low of $0.40 and a 52-week high of $4.29. The stock has a 50 day moving average price of $0.48 and a 200 day moving average price of $0.62. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 0.50.

Ainos (NASDAQ:AIMD) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($0.33) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 75.16% and a negative net margin of 15,348.14%.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.